Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Some of the two million AstraZeneca COVID-19 vaccine doses that Canada has secured at a facility in Milton, Ont., March 3, 2021.

Carlos Osorio/The Canadian Press

Prime Minister Justin Trudeau says he’s optimistic Canada will beat its September target to get COVID-19 shots to everyone in the country who wants them.

At a Wednesday news conference, Mr. Trudeau said the country’s eighth vaccine contract (announced last week with the Serum Institute of India) and the approval of more vaccines from Health Canada could help speed up the schedule for everyone to get their shots.

“We are very optimistic that we’re going to be able to accelerate some of these timelines,” Mr. Trudeau said.

Story continues below advertisement

The September goal to get all Canadians their shots relied only on deliveries from Pfizer-BioNTech and Moderna. Last week, Health Canada authorized the Oxford University-AstraZeneca shot and a comparable shot made by the Serum Institute. The Indian company is making the AstraZeneca vaccine through a different manufacturing process and the shot is sold under the name Covishield.

Tracking Canada’s COVID-19 vaccine rollout plans: A continuing guide

Oxford-AstraZeneca, Moderna or Pfizer: Which COVID-19 vaccine will I get in Canada?

Coronavirus tracker: How many COVID-19 cases are there in Canada and worldwide? The latest maps and charts

Canada hasn’t yet said when the 20 million shots it purchased directly from AstraZeneca will arrive, but they are expected only after March. To plug that gap, the government is buying two million doses from the Serum Institute, the first of which arrived on Wednesday.

India’s High Commissioner to Canada Ajay Bisaria said the federal government was able to secure that deal because Mr. Trudeau decided to call India’s Prime Minister Narendra Modi. The two have had a frosty relationship at times and, in December, the Indian government took Canada to task after Mr. Trudeau commented on farmer protests in India. But Mr. Bisaria said the two countries are now on a “good footing.”

During the Feb. 10 call between the two leaders, Mr. Bisaria said Mr. Trudeau “commended Prime Minister Modi for the dialogue going on with India’s farm leaders and the fact that it was going on following democratic principles.” He noted that Mr. Modi immediately made public his willingness to help the federal government after that meeting.

“That was the critical tipping point because ... at the end of the day there are political choices made when you apportion the vaccine among partners,” Mr. Bisaria said about the call and Canada’s success in buying the shots.

Canada will also receive 1.9 million shots of the AstraZeneca vaccine through the COVAX fund, which was primarily set up for low- and middle-income countries.

On top of those deliveries, Mr. Trudeau added that even more shots could start arriving in Canada if the federal regulator authorizes the shots from Johnson & Johnson and Novavax.

Story continues below advertisement

Vaccine candidates from both of these companies are currently being reviewed by Health Canada. It’s expected that the Johnson & Johnson vaccine will be the next one approved.

The federal government has not released any updated information about how much the vaccines are costing Canada. On Wednesday, The Canadian Press reported that federal budget documents show $5.3-billion was approved in December for COVID-19 vaccines and treatments, including the purchase of doses as well as research and development.

Another change that has the potential to speed up Canada’s inoculations are new guidelines released Wednesday by the National Advisory Committee on Immunization, which said provinces and territories can wait up to four months to administer the second shots of the vaccines that require two doses.

If that change is implemented, the committee said it would mean 80 per cent of people 16 years and older could get their first shot by the end of June.

Know what is happening in the halls of power with the day’s top political headlines and commentary as selected by Globe editors (subscribers only). Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies